|

Asthma Clinical Trials in Boston, MA

26 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsPhase 3<1 mi
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)—<1 mi
Investigating Dupilumab's Effect in Asthma by GenotypePhase 4<1 mi
Registry of Asthma Characterization and Recruitment 3 (RACR3)—<1 mi
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe AsthmaPhase 2<1 mi
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaPhase 3<1 mi
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway InflammationPhase 1<1 mi
Phenotyping Asthma for Bronchial Thermoplasty—<1 mi
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)Phase 3<1 mi
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled AsthmaPhase 4<1 mi
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate AsthmaPhase 1<1 mi
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaPhase 3<1 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaPhase 3<1 mi
Protocol CAUSE-03 / CHEETAH—<1 mi
Comparative-effectiveness of a Healthy Lifestyle and Asthma Management Program, In-person vs. ONlineN/A<1 mi
Automated Inhaler Monitoring for Asthma Medication UsageN/A<1 mi
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICUN/A<1 mi
Telehealth and Onsite Maintenance Exercise in Chronic Lung DiseaseN/A1 mi
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives—9 mi
Social Needs Screening and Chronic Diseases Study (WE CARE)N/A39 mi
Asthma Link Effectiveness TrialN/A39 mi
Individualizing Treatment for Asthma in Primary Care (Full Study)Phase 439 mi
Impact of Sleep Duration on Immune Balance in Urban Children With AsthmaN/A41 mi
The Puerto Rico Asthma Integrated Response Program ("PR-AIR")N/A41 mi
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe AsthmaPhase 446 mi
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA TreatmentPhase 349 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.